Tradestie Institutional Equity Comparison Engine
MMSI vs THOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MMSI Overall Edge
MMSI Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merit Medical Systems Inc (MMSI) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MMSI trades at 18.1x Forward P/E with 13.9% operating margin (+8.4% YoY revenue) versus THOR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MMSI sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against THOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MMSI
MMSI 18.1x vs THOR N/M Fwd P/E
Growth & Margin Winner
MMSI
Op Margin 13.9% vs N/A ยท YoY +8.4% vs N/A
Momentum & Technical Winner
MMSI
1Y +0.8% vs -1.4% ยท 52W Pos 70% vs 2%
Options & Structure Winner
MMSI
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
MMSI
NASDAQ
Merit Medical Systems Inc
Surgical & Medical Instruments & Apparatus
$84.34
-0.08% 1D
Market Cap
$5.1B
1M Return
-10.22%
1Y Return
+0.78%
Forward P/E
18.1x
Unified AI Score
64.7 / 100
BUY
Tech 73.0
Fund 59.0
Flow 50.0
Mom 50.0
THOR
US Equity
THOR
Institutional Equity
$24.63
-1.7% 1D
Market Cap
N/A
1M Return
-3.92%
1Y Return
-1.43%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 27.0
Fund 50.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MMSI +0.78%
THOR -1.43%
Spread: +26.81 pp (MMSI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MMSI TTM Op. Margin: 13.9%
THOR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MMSI vs THOR. Trailing 12-month operating profitability (MMSI 13.9% vs THOR N/A) and valuation multiples (MMSI 18.1x vs THOR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MMSI | THOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.1B | N/A | Larger Scale | MMSI |
| Trailing P/E Ratio Valuation | 31.6x | N/M | Lower Multiple | MMSI |
| Forward P/E Ratio Valuation | 18.1x | N/M | Lower Multiple | MMSI |
| Revenue Growth (YoY) Growth | +8.4% | N/A | Higher Growth | MMSI |
| Operating Margin (TTM) Profitability | 13.9% | N/A | Higher Margin | MMSI |
| Net Profit Margin Profitability | 9.9% | N/A | Higher Margin | MMSI |
| Return on Equity (ROE) Capital Efficiency | 9.8% | N/A | Higher ROE | MMSI |
| 52-Week Range Position Momentum | 70% ($60โ$95) | 2% ($25โ$29) | Stronger Trend | MMSI |
| Beta / 30D Volatility Risk Regime | 0.49ฮฒ ยท 42% Vol | 0.46ฮฒ ยท 17% Vol | Lower Realized Risk | THOR |
| Unified Institutional Score Composite Signal | 64.7 / 100 (BUY) | 44.5 / 100 (HOLD) | Higher Composite | MMSI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MMSI vs THOR Buy Guide
MMSI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
THOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MMSI nor THOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.